术前局部雌激素治疗不改善绝经后盆腔器官脱垂症状:随机对照双盲多中心研究
该随机、双盲、安慰剂对照、多中心研究纳入120例有症状的绝经后盆腔器官脱垂且计划手术修复的女性,术前6周局部应用雌激素霜或安慰剂霜。主要结局为治疗6周后使用德国盆底问卷评估的主观脱垂相关主诉差异。结果显示两组脱垂领域评分无显著差异(4.4±0.19 vs 4.6±0.19;均差-0.21;95%CI -0.74至0.33;P=0.445),表明术前局部雌激素不能改善脱垂相关症状。
要点
- 术前6周局部雌激素与安慰剂在改善脱垂相关症状上无差异。
- 研究为随机双盲安慰剂对照多中心设计,最终分析103例(86%)。
- 多因素分析显示无混杂因素改变对雌二醇的反应。
核心结论
- 术前局部应用雌激素不能改善有症状的绝经后盆腔器官脱垂女性的脱垂相关症状。
研究设计与样本
- 随机、双盲、安慰剂对照、多中心研究,纳入120例有症状的绝经后盆腔器官脱垂且计划手术修复的女性,随机分配接受局部雌激素霜或安慰剂霜治疗6周,最终103例(86%)纳入分析。
主要发现
- 治疗6周后,雌激素组与安慰剂组的脱垂领域评分无显著差异(4.4±0.19 vs 4.6±0.19;均差-0.21;95%CI -0.74至0.33;P=0.445)。
- 仅纳入接受干预女性的多因素分析显示,没有任何混杂因素改变对雌二醇的反应。
关键数值与推荐
- 主要结局为治疗6周后使用德国盆底问卷评估的主观脱垂相关主诉差异。
- 次要结局包括其他盆底相关主诉(膀胱、肠道或性功能)的差异。
临床怎么用
- 对于有症状的绝经后盆腔器官脱垂女性,术前局部雌激素治疗不应以改善脱垂相关症状为目的。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether locally applied vaginal estrogen affects prolapse-associated complaints compared with placebo treatment in postmenopausal women prior to surgical prolapse repair. DESIGN: Randomised, double-masked, placebo-controlled, multicentre study. SETTING: Urogynaecology unit at the Medical University of Vienna and University Hospital of Tulln. POPULATION: Postmenopausal women with symptomatic pelvic organ prolapse and planned surgical prolapse repair. METHODS: Women were randomly assigned local estrogen cream or placebo cream 6 weeks preoperatively. MAIN OUTCOME MEASURES: The primary outcome was differences in subjective prolapse-associated complaints after 6 weeks of treatment prior to surgery, assessed with the comprehensive German pelvic floor questionnaire. Secondary outcomes included differences in other pelvic floor-associated complaints (bladder, bowel or sexual function). RESULTS: Out of 120 women randomised, 103 (86%) remained for the final analysis. After 6 weeks of treatment the prolapse domain score did not differ between the estrogen and the placebo groups (4.4 ± 0.19 versus 4.6 ± 0.19; mean difference, -0.21; 95% CI -0.74 to 0.33; P = 0.445). Multivariate analysis, including only women receiving the intervention, showed that none of the confounding factors modified the response to estradiol. CONCLUSIONS: These results demonstrate that preoperative locally applied estrogen does not ameliorate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse. TWEETABLE ABSTRACT: Preoperative local estrogen does not ameliorate prolapse-associated symptoms in postmenopausal women with pelvic organ prolapse.
引用
- Marschalek ML, Bodner K, Kimberger O, et al. Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study. BJOG. 2021. PMID: 34464489. doi:10.1111/1471-0528.16894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。